NCT06510699 2026-04-16
PRAGMATIC
The University of Queensland
Phase 2 Recruiting
Clinical Trials
23 trialsNCT03828773 2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA Recruiting
NCT01503515 2024-10-16
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT06582186 2024-09-03
VORIPRECI
University Hospital, Grenoble
Phase 4 Not yet recruiting
NCT01288378 2023-12-11
Empirical Versus Preemptive Antifungal Therapy
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00896493 2023-05-11
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Stanford University
Phase 2 Completed
NCT03434704 2022-07-19
SIR-POSA
IRCCS San Raffaele
Phase 2 Completed
NCT01307579 2021-03-30
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Children's Oncology Group
Phase 3 Completed
NCT03301597 2021-03-30
LAUNCH
Nohla Therapeutics, Inc.
Phase 2 Terminated
NCT02358499 2020-12-22
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Children's Mercy Hospital Kansas City
Phase 1 Completed
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT03159364 2019-09-19
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT00936117 2019-02-27
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01615809 2018-03-29
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Fundació Sant Joan de Déu
Phase 2 Completed
NCT00686543 2017-04-07
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00044486 2017-03-10
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT00185965 2014-08-01
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Stanford University
Phase 1/2 Completed
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00501098 2009-09-22
PROFIL-C
Northern Italy Leukemia Group
Phase 2 Completed
NCT00336531 2008-11-19
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Samsung Medical Center
Phase 4 Completed
NCT00015665 2008-03-04
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00002277 2005-06-24
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NIH AIDS Clinical Trials Information Service
Phase 3 Completed